Tevaarwerk, A., Wilding, G., Eickhoff, J., Chappell, R., Sidor, C., Arnott, J., … Liu, G. (2012). Phase I study of continuous MKC-1 in patients with advanced or metastatic solid malignancies using the modified Time-to-Event Continual Reassessment Method (TITE-CRM) dose escalation design. Investigational New Drugs, 30(3), 1039-45. https://doi.org/10.1007/s10637-010-9629-6 (Original work published 2012)